C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/445 (2006.01) C07D 491/056 (2006.01)
Patent
CA 2281918
The invention relates to novel oxazolidine derivatives of formula (I), wherein R1, R2 and R3 have the meaning cited in Claim 1. The invention further relates to the salts thereof and to a method for the production of the inventive compounds. The compounds of formula (I) act as 5-HT2A antagonists having a reuptake-inhibiting, antidepressant or anxiolytic effect and can be used in the production of medicaments.
L'invention concerne de nouveaux dérivés d'oxazolidine de la formule (I) dans laquelle R<1>, R<2> et R<3> ont les significations mentionnées dans la revendication 1. L'invention concerne également leurs sels et un procédé permettant de préparer ces composés. Les composés de la formule (I) agissent comme 5-HT2A-antagonistes ayant une action inhibitrice de la réabsorption, antidépressive ou anxiolytique et s'utilisent pour préparer des médicaments.
Bartoszyk Gerd
Bottcher Henning
Greiner Hartmut
Prucher Helmut
Seyfried Christoph
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Oxazolidines as 5-ht2a-antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidines as 5-ht2a-antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidines as 5-ht2a-antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1385360